Skip to main content

SI-BONE, Inc.

SIBN
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001459839

In the last 90 days, SI-BONE, Inc. insiders filed 0 open-market purchases and 11 sales; 167 institutions reported holding it in 13F filings for Q2 2026, worth $773.9M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding SI-BONE, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of SIBN: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders134122−12
Shares30.6M31.2M+597.5K (+2.0%)
Value$962.2M$668.2M−$293.9M (−30.5%)

New holders (14)

Institutions that held SI-BONE, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to SIBN in Q3 2021
InstitutionSharesValue% of portfolio
Balyasny Asset Management LLC193,753$4.15M0.02%
Eversept Partners, LP150,000$3.21M0.26%
Crestline Management, LP134,913$2.89M0.27%
CastleArk Alternatives, LLC54,227$1.16M0.04%
Cinctive Capital Management LP41,091$880.0K0.05%
Jump Financial, LLC16,136$346.0K0.02%
HRT Financial LP12,601$269.0K0.00%
Connor, Clark & Lunn Investment Management Ltd.12,020$257.0K0.00%
Schonfeld Strategic Advisors LLC10,146$218.0K0.00%
Voloridge Investment Management, LLC10,138$217.0K0.00%
FMR LLC7,109$152.0K0.00%
Cutler Group LP5,000$107.0K0.01%
Maverick Capital LtdSuperinvestorMaverick Capital3,076$66.0K0.00%
Webster Bank, N. A.1,695$36.0K0.00%

Sold out (26)

Institutions that held SI-BONE, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.